DarioHealth Corp. (DRIO) Return on equity 2017–2025
DarioHealth Corp. (DRIO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-61.4%FY2025 · since FY2017: -399.5% → -61.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -61.4% | -2.1 pp |
| FY2024 | -59.4% | +42.9 pp |
| FY2023 | -102.2% | -24.5 pp |
| FY2022 | -77.7% | +12.0 pp |
| FY2021 | -89.7% | +14.9 pp |
| FY2020 | -104.6% | -10.7 pp |
| FY2019 | -93.9% | +105.6 pp |
| FY2018 | -199.5% | +200.0 pp |
| FY2017 | -399.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More DRIO financial trends
DRIO RevenueDRIO Net incomeDRIO Net marginDRIO Gross profitDRIO Gross marginDRIO Operating incomeDRIO Operating marginDRIO Operating cash flowDRIO Free cash flowDRIO Capital expendituresDRIO Stock buybacksDRIO Dividends paidDRIO Total assetsDRIO Total liabilitiesDRIO Shareholders’ equityDRIO overview →